Development of a penem antibiotic against Mycobacteroides abscessus

Batchelder et al. report a new penem class antibiotic, T405, which exhibits potent activity against M. abscessus and clinical isolates from cystic fibrosis patients. The development of resistance to T405 is inhibited with the addition of a β-lactamase inhibitor, avibactam. Its clinical potential is...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hunter R. Batchelder, Elizabeth Story-Roller, Evan P. Lloyd, Amit Kaushik, Kristina M. Bigelow, Emily C. Maggioncalda, Eric L. Nuermberger, Gyanu Lamichhane, Craig A. Townsend
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Acceso en línea:https://doaj.org/article/5e507dd0a49447c7b96b6dc7becd6906
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5e507dd0a49447c7b96b6dc7becd6906
record_format dspace
spelling oai:doaj.org-article:5e507dd0a49447c7b96b6dc7becd69062021-12-02T15:18:51ZDevelopment of a penem antibiotic against Mycobacteroides abscessus10.1038/s42003-020-01475-22399-3642https://doaj.org/article/5e507dd0a49447c7b96b6dc7becd69062020-12-01T00:00:00Zhttps://doi.org/10.1038/s42003-020-01475-2https://doaj.org/toc/2399-3642Batchelder et al. report a new penem class antibiotic, T405, which exhibits potent activity against M. abscessus and clinical isolates from cystic fibrosis patients. The development of resistance to T405 is inhibited with the addition of a β-lactamase inhibitor, avibactam. Its clinical potential is further demonstrated by T405 displaying a favourable pharmacokinetic profile in mice with an absence of toxicity.Hunter R. BatchelderElizabeth Story-RollerEvan P. LloydAmit KaushikKristina M. BigelowEmily C. MaggioncaldaEric L. NuermbergerGyanu LamichhaneCraig A. TownsendNature PortfolioarticleBiology (General)QH301-705.5ENCommunications Biology, Vol 3, Iss 1, Pp 1-5 (2020)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Hunter R. Batchelder
Elizabeth Story-Roller
Evan P. Lloyd
Amit Kaushik
Kristina M. Bigelow
Emily C. Maggioncalda
Eric L. Nuermberger
Gyanu Lamichhane
Craig A. Townsend
Development of a penem antibiotic against Mycobacteroides abscessus
description Batchelder et al. report a new penem class antibiotic, T405, which exhibits potent activity against M. abscessus and clinical isolates from cystic fibrosis patients. The development of resistance to T405 is inhibited with the addition of a β-lactamase inhibitor, avibactam. Its clinical potential is further demonstrated by T405 displaying a favourable pharmacokinetic profile in mice with an absence of toxicity.
format article
author Hunter R. Batchelder
Elizabeth Story-Roller
Evan P. Lloyd
Amit Kaushik
Kristina M. Bigelow
Emily C. Maggioncalda
Eric L. Nuermberger
Gyanu Lamichhane
Craig A. Townsend
author_facet Hunter R. Batchelder
Elizabeth Story-Roller
Evan P. Lloyd
Amit Kaushik
Kristina M. Bigelow
Emily C. Maggioncalda
Eric L. Nuermberger
Gyanu Lamichhane
Craig A. Townsend
author_sort Hunter R. Batchelder
title Development of a penem antibiotic against Mycobacteroides abscessus
title_short Development of a penem antibiotic against Mycobacteroides abscessus
title_full Development of a penem antibiotic against Mycobacteroides abscessus
title_fullStr Development of a penem antibiotic against Mycobacteroides abscessus
title_full_unstemmed Development of a penem antibiotic against Mycobacteroides abscessus
title_sort development of a penem antibiotic against mycobacteroides abscessus
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/5e507dd0a49447c7b96b6dc7becd6906
work_keys_str_mv AT hunterrbatchelder developmentofapenemantibioticagainstmycobacteroidesabscessus
AT elizabethstoryroller developmentofapenemantibioticagainstmycobacteroidesabscessus
AT evanplloyd developmentofapenemantibioticagainstmycobacteroidesabscessus
AT amitkaushik developmentofapenemantibioticagainstmycobacteroidesabscessus
AT kristinambigelow developmentofapenemantibioticagainstmycobacteroidesabscessus
AT emilycmaggioncalda developmentofapenemantibioticagainstmycobacteroidesabscessus
AT ericlnuermberger developmentofapenemantibioticagainstmycobacteroidesabscessus
AT gyanulamichhane developmentofapenemantibioticagainstmycobacteroidesabscessus
AT craigatownsend developmentofapenemantibioticagainstmycobacteroidesabscessus
_version_ 1718387447411245056